Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years, Semin Arthritis Rheum, vol.46, pp.537-580, 2017. ,
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease, N Engl J Med, vol.380, pp.2518-2546, 2019. ,
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases, N Engl J Med, vol.381, pp.1718-1727, 2019. ,
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease. Arthritis & rheumatology, vol.71, pp.972-82, 2019. ,
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18, Arthritis & rheumatology, vol.71, pp.2059-67, 2019. ,
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis, Chest, vol.150, pp.299-306, 2016. ,
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, vol.31, pp.315-339, 1988. ,
Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, vol.62, pp.2569-81, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01557559
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease, N Engl J Med, vol.379, pp.2209-2228, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02191891
Interstitial lung disease in systemic sclerosis: a simple staging system, Am J Respir Crit Care Med, vol.177, pp.1248-54, 2008. ,
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model, Ann Rheum Dis, vol.77, pp.1326-1358, 2018. ,
Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand? Semin Arthritis Rheum ,
, , pp.30006-30014
A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18, Am J Respir Crit Care Med, vol.173, pp.781-92, 2006. ,
Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin, Lung, vol.175, pp.379-85, 1997. ,
Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease, Arthritis Res Ther, vol.21, p.30764869, 2019. ,
Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts, BMJ open, vol.9, 2019. ,
Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT, Respir Med, vol.98, pp.1131-1138, 2004. ,
Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease, PLoS One, vol.15, 2020. ,